Tsukuba, Japan

Makoto Ando


Average Co-Inventor Count = 6.4

ph-index = 2

Forward Citations = 26(Granted Patents)


Company Filing History:


Years Active: 2004-2006

Loading Chart...
4 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Makoto Ando

Introduction

Makoto Ando is a prominent inventor based in Tsukuba, Japan. He has made significant contributions to the field of pharmaceuticals, particularly through his innovative compounds. With a total of 4 patents, Ando's work has the potential to impact various medical conditions.

Latest Patents

Ando's latest patents include N-substituted-2-oxodihydropyridine derivatives, which are compounds that can be utilized in treating a range of diseases related to neuropeptide Y (NPY). These compounds are designed to address cardiovascular disorders such as angina and heart failure, as well as nervous system disorders including depression and anxiety. Additionally, his work on pyridone derivatives offers potential treatments for metabolic diseases like obesity and diabetes, along with reproductive and gastrointestinal disorders.

Career Highlights

Makoto Ando is currently associated with Banyu Pharmaceutical Co. Ltd., where he continues to develop innovative pharmaceutical solutions. His expertise in medicinal chemistry has led to advancements that could significantly improve patient outcomes in various health conditions.

Collaborations

Ando has collaborated with notable colleagues such as Nagaaki Sato and Tsuyoshi Nagase. These partnerships have fostered a collaborative environment that enhances the research and development of new therapeutic compounds.

Conclusion

Makoto Ando's contributions to the field of pharmaceuticals through his patents and collaborative efforts highlight his role as an influential inventor. His work continues to pave the way for innovative treatments that address critical health issues.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…